Minute Molecular Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Minute Molecular General Information

Description

Developer of a molecular diagnostics device designed to provide rapid immunoassays. The company's device has the ability to use various sample types such as nasal swabs, saliva, and whole blood, and quantitatively report a viral load, enabling medical professionals to get testing results quickly.

Contact Information

Website
www.m2dx.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 1800 Sherman Avenue
  • Suite 504
  • Evanston, IL 60201
  • United States
Primary Industry
Diagnostic Equipment
Acquirer
Vertical(s)
Corporate Office
  • 1800 Sherman Avenue
  • Suite 504
  • Evanston, IL 60201
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Minute Molecular Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 12-May-2023 Completed Generating Revenue
6. Later Stage VC 22-Mar-2023 Completed Generating Revenue
5. Grant 26-Apr-2021 Completed Generating Revenue
4. Early Stage VC (Series B) 19-Apr-2021 Completed Generating Revenue
3. Early Stage VC (Series A1) 22-Nov-2019 Completed Generating Revenue
2. Early Stage VC 13-Aug-2018 $1.09M $2.39M Completed Startup
1. Early Stage VC (Series A) 23-May-2017 $1.3M $1.3M Completed Startup
To view Minute Molecular’s complete valuation and funding history, request access »

Minute Molecular Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A-3
Series A-2
Series A-1
Series AA-2 300,000 $0.000100 $5 $5 1x $5 12.04%
Series AA-1 700,000 $0.000100 $2.21 $2.21 1x $2.21 28.08%
To view Minute Molecular’s complete cap table history, request access »

Minute Molecular Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a molecular diagnostics device designed to provide rapid immunoassays. The company's device has the ability
Diagnostic Equipment
Evanston, IL

Abingdon, United Kingdom
 

Mechelen, Belgium
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Minute Molecular Competitors (30)

One of Minute Molecular’s 30 competitors is Sense Biodetection, a Formerly VC-backed company based in Abingdon, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sense Biodetection Formerly VC-backed Abingdon, United Kingdom
Biocartis Venture Capital-Backed Mechelen, Belgium
Hain Lifescience Corporate Backed or Acquired Nehren, Germany
New World Technologies Corporation New York, NY
Avalun Formerly VC-backed Grenoble, France
You’re viewing 5 of 30 competitors. Get the full list »

Minute Molecular Patents

Minute Molecular Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022267252-A1 Analyte detection cartridge and methods of use thereof Pending 27-Apr-2021
CA-3217441-A1 Analyte detection cartridge and methods of use thereof Pending 27-Apr-2021
EP-4329936-A1 Analyte detection cartridge and methods of use thereof Pending 27-Apr-2021
EP-4329936-A4 Analyte detection cartridge and methods of use thereof Pending 27-Apr-2021
WO-2022232281-A1 Analyte detection cartridge and methods of use thereof Inactive 27-Apr-2021 C12N15/1013
To view Minute Molecular’s complete patent history, request access »

Minute Molecular Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institute of Biomedical Imaging and Bioengineering Government
To view Minute Molecular’s complete investors history, request access »

Minute Molecular FAQs

  • When was Minute Molecular founded?

    Minute Molecular was founded in 2017.

  • Where is Minute Molecular headquartered?

    Minute Molecular is headquartered in Evanston, IL.

  • What industry is Minute Molecular in?

    Minute Molecular’s primary industry is Diagnostic Equipment.

  • Is Minute Molecular a private or public company?

    Minute Molecular is a Private company.

  • What is Minute Molecular’s current revenue?

    The current revenue for Minute Molecular is .

  • How much funding has Minute Molecular raised over time?

    Minute Molecular has raised $14.1M.

  • Who are Minute Molecular’s investors?

    National Institute of Biomedical Imaging and Bioengineering has invested in Minute Molecular.

  • Who are Minute Molecular’s competitors?

    Sense Biodetection, Biocartis, Hain Lifescience, New World Technologies, and Avalun are some of the 30 competitors of Minute Molecular.

  • When was Minute Molecular acquired?

    Minute Molecular was acquired on 12-May-2023.

  • Who acquired Minute Molecular?

    Minute Molecular was acquired by Nuclein.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process